PEG-interleukin-2
Term · Oncology and biomedicine · MLC-T-ONC-015910
A complex of polyethylene glycol conjugated with human recombinant cytokine interleukin-2 (IL-2) with antineoplastic activity. PEG-interleukin-2 induces natural killer (NK) cell activity and the production of interferon-gamma (IFN-gamma), and enhances T cell-mediated cytotoxicity. Pegylation of IL-2 protects the cytokine from degradation.
| Identifier | MLC-T-ONC-015910 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | PEG-IL-2 |
| Synonyms | polyethylene glycol-modified recombinant interleukin-2 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015910",
"term": "PEG-interleukin-2",
"field": "Oncology and biomedicine",
"definition": "A complex of polyethylene glycol conjugated with human recombinant cytokine interleukin-2 (IL-2) with antineoplastic activity. PEG-interleukin-2 induces natural killer (NK) cell activity and the production of interferon-gamma (IFN-gamma), and enhances T cell-mediated cytotoxicity. Pegylation of IL-2 protects the cytokine from degradation.",
"abbreviation": "PEG-IL-2",
"synonyms": [
"polyethylene glycol-modified recombinant interleukin-2"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/peg-interleukin-2/"
}
Record 12,847 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.